US 7183415
Quinoline compound
granted A61KA61K31/47A61K31/4709
Quick answer
US patent 7183415 (Quinoline compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/47, A61K31/4709, A61K31/496, A61K31/5377